Advertisement
ELAN vs ZTS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a StrongBuy and ZTS is a StrongBuy.
ELAN's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for ELAN turned positive on October 05, 2026. Looking at past instances where ELAN's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on ELAN as a result. In 47 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAN advanced for three days, in 172 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 54 cases where ELAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
ELAN moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ELAN moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
ELAN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ELAN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. ELAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.710) is normal, around the industry mean (11.138). P/E Ratio (-55.000) is within average values for comparable stocks, (-7.600). Projected Growth (PEG Ratio) (4.042) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (2.275) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Momentum Indicator for ZTS turns positive, indicating new upward trend
ZTS saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In 52 of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ZTS just turned positive on October 06, 2026. Looking at past instances where ZTS's MACD turned positive, the stock continued to rise in 25 of 48 cases over the following month. The odds of a continued upward trend are 52%.
ZTS moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ZTS crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 31%.
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZTS advanced for three days, in 142 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
ZTS broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ZTS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 18 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ZTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.451) is normal, around the industry mean (11.138). P/E Ratio (12.989) is within average values for comparable stocks, (-7.600). ZTS's Projected Growth (PEG Ratio) (6.647) is slightly higher than the industry average of (2.152). Dividend Yield (0.027) settles around the average of (0.038) among similar stocks. P/S Ratio (3.299) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
ELAN | ZTS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 61 Fair valued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 18 | |
PRICE GROWTH RATING 1..100 | 56 | 58 | |
P/E GROWTH RATING 1..100 | 100 | 88 | |
SEASONALITY SCORE 1..100 | n/a | 14 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELAN's Valuation (61) in the Agricultural Commodities Or Milling industry is in the same range as ZTS (87) in the Pharmaceuticals Generic industry. This means that ELAN’s stock grew similarly to ZTS’s over the last 12 months.
ELAN's Profit vs Risk Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that ELAN’s stock grew similarly to ZTS’s over the last 12 months.
ZTS's SMR Rating (18) in the Pharmaceuticals Generic industry is significantly better than the same rating for ELAN (92) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew significantly faster than ELAN’s over the last 12 months.
ELAN's Price Growth Rating (56) in the Agricultural Commodities Or Milling industry is in the same range as ZTS (58) in the Pharmaceuticals Generic industry. This means that ELAN’s stock grew similarly to ZTS’s over the last 12 months.
ZTS's P/E Growth Rating (88) in the Pharmaceuticals Generic industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.
| ELAN | ZTS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 63% |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 57% | 1 day ago 58% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 52% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 55% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 50% |
| Advances ODDS (%) | 7 days ago 66% | 3 days ago 50% |
| Declines ODDS (%) | 1 day ago 76% | 22 days ago 62% |
| BollingerBands ODDS (%) | 1 day ago 75% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 66% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELAN’s FA Score shows that 0 FA rating(s) are green while ZTS’s FA Score has 1 green FA rating(s).
- ELAN’s FA Score: 0 green, 5 red.
- ZTS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELAN’s TA Score shows that 3 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).
- ELAN’s TA Score: 3 bullish, 6 bearish.
- ZTS’s TA Score: 5 bullish, 5 bearish.
Price Growth
ELAN (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +5.75% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.91%. For the same industry, the average monthly price growth was -7.64%, and the average quarterly price growth was +9.46%.
Reported Earning Dates
ELAN is expected to report earnings on Nov 06, 2026.
ZTS is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.91% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
ELAN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with PAHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then PAHC could also see price increases.
| Ticker / NAME | Correlation To ELAN | 1D Price Change % | ||
|---|---|---|---|---|
| ELAN | 100% | -0.66% | ||
| PAHC - ELAN | 51% Loosely correlated | +1.16% | ||
| ZTS - ELAN | 44% Loosely correlated | -0.52% | ||
| SNDL - ELAN | 39% Loosely correlated | N/A | ||
| PRGO - ELAN | 37% Loosely correlated | -1.61% | ||
| VTRS - ELAN | 34% Loosely correlated | -1.07% | ||
More | ||||
ZTS and
Correlation & Price change
A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with PAHC. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then PAHC could also see price increases.
| Ticker / NAME | Correlation To ZTS | 1D Price Change % | ||
|---|---|---|---|---|
| ZTS | 100% | -0.52% | ||
| PAHC - ZTS | 58% Loosely correlated | +1.16% | ||
| ELAN - ZTS | 44% Loosely correlated | -0.66% | ||
| AMPH - ZTS | 36% Loosely correlated | +1.00% | ||
| HLN - ZTS | 35% Loosely correlated | -1.47% | ||
| SNDL - ZTS | 33% Loosely correlated | N/A | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| CVC.X | 0.023431 | 0.000743 | +3.28% |
| Civic cryptocurrency | |||
| BURGER.X | 0.000669 | 0.000009 | +1.38% |
| BurgerCities cryptocurrency | |||
| ATOM.X | 1.748878 | 0.000038 | N/A |
| Cosmos cryptocurrency | |||
| POLS.X | 0.061698 | -0.000051 | -0.08% |
| Polkastarter cryptocurrency | |||
| KSM.X | 4.165826 | -0.118887 | -2.77% |
| Kusama cryptocurrency | |||